← All Bicycle Therapeutics PLC filings

Bicycle Therapeutics PLC Form 4 insider transactions

NASDAQ
BCYC
Bicycle Therapeutics PLC
Form 4: Bicycle Therapeutics COO Sells Shares to Cover Tax Obligations
Alistair Milnes, Chief Operating Officer of Bicycle Therapeutics plc, sold 955 ordinary shares on April 3, 2024, to cover tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs).
NASDAQ
BCYC
Bicycle Therapeutics PLC
Form 4: Bicycle Therapeutics' Chief Scientific Officer Sells Shares to Cover Tax Obligations
Nicholas Keen, Chief Scientific Officer of Bicycle Therapeutics plc, sold 790 ordinary shares on April 3, 2024, to cover tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs).
NASDAQ
BCYC
Bicycle Therapeutics PLC
Form 4: Bicycle Therapeutics Executive Sells Shares to Cover Tax Obligations
Nigel Crockett, Chief Business Officer of Bicycle Therapeutics, sold 955 ordinary shares to cover tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs).
NASDAQ
BCYC
Bicycle Therapeutics PLC
Form 4: Bicycle Therapeutics' Chief Accounting Officer Sells Shares to Cover Tax Obligations
Travis Alvin Thompson, Chief Accounting Officer of Bicycle Therapeutics plc, sold 152 ordinary shares on April 3, 2024, to cover statutory tax withholding obligations related to the vesting and settlement of RSUs.
NASDAQ
BCYC
Bicycle Therapeutics PLC
Form 4: Bicycle Therapeutics Executive Granted Stock Options
Michael Charles Ferguson Hannay, Chief Product & Supply Chain Officer at Bicycle Therapeutics, was granted stock options for 58,000 ordinary shares on March 19, 2024.